Date: March 11, 2021
Time: 8:00am (PST), 11:00am (EST)
Identifying the toxicity profile of a compound is a necessity across industries and the various stages of drug development. Early stage mechanism-based in vitro assays can not only speed up the compound development pipeline, but also can reduce animal testing requirements. Information about the mode-of-action of genotoxic compounds can be vital for both screening and regulatory applications.
In this webinar, Miltenyi Biotec and Toxys will highlight the potential of using flow cytometry for high content toxicity analysis. We will introduce the ToxTracker® Suite and you will learn about the opportunities, advantages and challenges faced when using this assay for mechanistic toxicity testing.
Webinars will be available for unlimited on-demand viewing after live event.